Polar Asset Management Partners’s Harvard Bioscience HBIO Stock Holding History

Polar Asset Management Partners’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-104,836	Closed	-$2.85M	–	292
2016 Q3	$2.85M	Sell	104,836 -59,234	-36%	-$1.64M	0.13%	171
2016 Q2	$4.69M	Sell	164,070 -6,959	-4%	-$221K	0.27%	133
2016 Q1	$5.17M	Sell	171,029 -670	-0.4%	-$19K	0.31%	112
2015 Q4	$5.96M	Buy	171,699 +20,243	+13%	+$692K	0.38%	90
2015 Q3	$5.72M	Buy	151,456 +73,453	+94%	+$3.42M	0.42%	94
2015 Q2	$4.45M	Buy	78,003 +4,358	+6%	+$248K	0.26%	120
2015 Q1	$4.29M	Buy	+73,645	New	+$3.96M	0.28%	123

Other funds holding HBIO

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Glacier Peak Capital Bellevue, Washington $94.6M AUM 0.45% 1-Year Est. Return

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return